Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles 2022: Technologies Driving Biological Investigations

Yong Zeng's Biography



Yong Zeng, Associate Professor, University of Florida

Dr. Zeng is an associate professor of chemistry and affiliate faculty of Biomedical Engineering at the University of Florida, and a member of UF Health Cancer Center. He obtained his PhD in Chemistry from University of Alberta, Canada and completed the postdoc training at University of California, Berkeley. Dr. Zeng’s research draws on chemistry, nanomaterials, bioengineering, and medicine to develop innovative micro and nanoscale tools to advance precision medicine of cancer. His technology innovations span from biomolecular assays to micro/nano systems for sensitive measurements of liquid biopsies and molecular biomarkers. His group is also devoted to translational research to bring the technological innovations to clinical sciences, closely collaborating with biologists and clinicians. Dr. Zeng is internationally recognized for his pioneering research in developing microfluidic technologies for isolation and analysis of tumor-derived extracellular vesicles (EVs) for cancer diagnostics and therapeutics. His research programs have been continuously funded by NIH and other funding agencies and led to many highly visible publications on top-tier journals, including Nat. Biomed. Eng. and Sci. Transl. Med., which were featured in public media outlets such as the NIH Director’s Blog and the JAMA Network.

Yong Zeng Image

Advancing Cancer Liquid Biopsy with Microfluidics and Nanoengineering

Tuesday, 13 December 2022 at 09:30

Add to Calendar ▼2022-12-13 09:30:002022-12-13 10:30:00Europe/LondonAdvancing Cancer Liquid Biopsy with Microfluidics and NanoengineeringExtracellular Vesicles 2022: Technologies Driving Biological Investigations in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com

A primary focus of my research is on the development of innovative microfluidics and nanobiosensing technologies and molecular biomarkers for cancer diagnosis and treatment. Herein, we will discuss some of the nanoengineered microfluidic systems for efficient immunoisolation of circulating extracellular vesicles (EVs) and ultrasensitive profiling of EV biomarkers, including proteins and miRNAs.  Adaptation of our new technologies to clinical studies of circulating EVs for non-invasive liquid biopsy of cancer will be discussed.


Add to Calendar ▼2022-12-12 00:00:002022-12-14 00:00:00Europe/LondonExtracellular Vesicles 2022: Technologies Driving Biological InvestigationsExtracellular Vesicles 2022: Technologies Driving Biological Investigations in Long Beach, CaliforniaLong Beach, CaliforniaSELECTBIOenquiries@selectbiosciences.com